Olivier Drouin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Olivier Drouin has a total of 313 co-authors. Here are the top co-authors by number of shared publications:
- Tamara Perez
Centre de recherche Azrieli du Centre Hospitalier Universitaire Sainte-Justine, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada
11 shared publications - Jocelyn Gravel
Centre de recherche Azrieli du CHU Sainte-Justine, Montréal, Québec, Canada
7 shared publications - Nicholas Chadi
Université de Montréal
7 shared publications - Fatima Kakkar
Division of Infectious Diseases, CHU Sainte-Justine, Montréal, Canada
6 shared publications - Shaun K. Morris
Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada; Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
5 shared publications Anupam Sehgal
Queen’s University, Kingston, Ontario, Canada
4 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
SARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing
Background: Co-circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with other respiratory viruses raised concerns that coinfections may increase pediatric coronavirus disease 2019 (COVID-19) severity, but evidence is limited by variable testing practices. We assessed the epidemiology and outcomes of SARS-CoV-2 respiratory viral coinfections in hospitalized children. Methods: We analyzed national surveillance data from the Canadian Immunization Monitoring Program, ACTive (IMPACT) COVID-19 study. Children aged <17 years hospitalized with confirmed COVID-19 during Delta and Omicron periods were included. Coinfection was defined as SARS-CoV-2 plus ≥1 additional respiratory virus. Primary analyses were restricted to centres with systematic multiplex polymerase chain reaction (PCR) testing of all admissions with acute respiratory illness (n = 5), while secondary analyses included all centres (n = 13). Associations with outcomes (respiratory support, ventilation, intensive care and severe COVID-19) were estimated using multivariable mixed-effects logistic regression and adjusted odds ratios (aORs). Results: Among 2831 hospitalized children, 938 were admitted at centers with systematic multiplex PCR testing, among whom 18.6% had ≥1 respiratory viral coinfection. Respiratory syncytial virus (39.7%) and enterovirus/rhinovirus (38.5%) coinfections were the most common. Coinfections were not associated with increased odds of severe COVID-19 in centers with systematic multiplex PCR testing (aOR 0.94; 95% confidence interval, 0.76–1.15). In secondary analyses including all centers irrespective of testing strategy, coinfections were associated with increased odds of severe COVID-19 (aOR 1.42; 95% confidence interval, 1.05–1.91). Conclusions: In centers that systematically conducted multiplex PCR testing, SARS-CoV-2 respiratory viral coinfections were not associated with increased COVID-19 severity. Differences observed when including centers without systematic testing underscore the importance of considering testing strategies when evaluating the clinical impact of coinfections.
- 10 September 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
Open AccessSARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing
Background: Co-circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with other respiratory viruses raised concerns that coinfections may increase pediatric coronavirus disease 2019 (COVID-19) severity, but evidence is limited by variable testing practices. We assessed the epidemiology and outcomes of SARS-CoV-2 respiratory viral coinfections in hospitalized children. Methods: We analyzed national surveillance data from the Canadian Immunization Monitoring Program, ACTive (IMPACT) COVID-19 study. Children aged <17 years hospitalized with confirmed COVID-19 during Delta and Omicron periods were included. Coinfection was defined as SARS-CoV-2 plus ≥1 additional respiratory virus. Primary analyses were restricted to centres with systematic multiplex polymerase chain reaction (PCR) testing of all admissions with acute respiratory illness (n = 5), while secondary analyses included all centres (n = 13). Associations with outcomes (respiratory support, ventilation, intensive care and severe COVID-19) were estimated using multivariable mixed-effects logistic regression and adjusted odds ratios (aORs). Results: Among 2831 hospitalized children, 938 were admitted at centers with systematic multiplex PCR testing, among whom 18.6% had ≥1 respiratory viral coinfection. Respiratory syncytial virus (39.7%) and enterovirus/rhinovirus (38.5%) coinfections were the most common. Coinfections were not associated with increased odds of severe COVID-19 in centers with systematic multiplex PCR testing (aOR 0.94; 95% confidence interval, 0.76–1.15). In secondary analyses including all centers irrespective of testing strategy, coinfections were associated with increased odds of severe COVID-19 (aOR 1.42; 95% confidence interval, 1.05–1.91). Conclusions: In centers that systematically conducted multiplex PCR testing, SARS-CoV-2 respiratory viral coinfections were not associated with increased COVID-19 severity. Differences observed when including centers without systematic testing underscore the importance of considering testing strategies when evaluating the clinical impact of coinfections.
- 9 September 2026
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
Adverse events related to paediatric virtual care: a prospective surveillance study
Objectives: Many children and families experience benefits of virtual care such as improved accessibility and reduced need for arranging respite care and transportation, but it may have limitations that compromise healthcare quality and result in adverse events (AEs). The objective of this study was to describe the burden and nature of recognized AEs suspected to be related to virtual care delivered to children in Canada between 2023 and 2025. Methods: Through the established methodology of the Canadian Paediatric Surveillance Program, over 2800 paediatricians and paediatric subspecialists were surveyed monthly for 2 years (February 2023 to January 2025) to report new cases of AEs related to virtual care, defined as either missed, delayed, or inaccurate diagnoses or emergencies without the ability to respond, among children in Canada aged 0 to 18 years. Results: Nine reports on eight children met the case definition. The majority were male. Median age was 13.7 years with most children between the ages of 12 and 14 years. Reports were from three different provinces with the majority in Ontario. Of the AEs, most were delayed diagnoses and the remainder were either incorrect diagnosis or missed diagnosis; there were no reported emergencies without the ability to respond. Conclusion: Our results show that virtual care can be safely provided in paediatric settings when appropriate safeguards and clinical judgment are employed. Evidence-based guidelines will be essential for establishing best-practice standards that minimize risks while maximizing the benefits of virtual care for children.
- 9 September 2026
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
Adverse events related to paediatric virtual care: a prospective surveillance study
Objectives: Many children and families experience benefits of virtual care such as improved accessibility and reduced need for arranging respite care and transportation, but it may have limitations that compromise healthcare quality and result in adverse events (AEs). The objective of this study was to describe the burden and nature of recognized AEs suspected to be related to virtual care delivered to children in Canada between 2023 and 2025. Methods: Through the established methodology of the Canadian Paediatric Surveillance Program, over 2800 paediatricians and paediatric subspecialists were surveyed monthly for 2 years (February 2023 to January 2025) to report new cases of AEs related to virtual care, defined as either missed, delayed, or inaccurate diagnoses or emergencies without the ability to respond, among children in Canada aged 0 to 18 years. Results: Nine reports on eight children met the case definition. The majority were male. Median age was 13.7 years with most children between the ages of 12 and 14 years. Reports were from three different provinces with the majority in Ontario. Of the AEs, most were delayed diagnoses and the remainder were either incorrect diagnosis or missed diagnosis; there were no reported emergencies without the ability to respond. Conclusion: Our results show that virtual care can be safely provided in paediatric settings when appropriate safeguards and clinical judgment are employed. Evidence-based guidelines will be essential for establishing best-practice standards that minimize risks while maximizing the benefits of virtual care for children.
- Open Access
- 26 June 2026
- Published by JMIR Publications Inc. in JMIR Pediatrics and Parenting
- Vol. 9, e84304
Codevelopment of a Digital Screening and Intervention Tool to Improve Lifestyle Habits in Children: Focus Group Study With Parents and Clinicians
Background: Chronic preventable diseases represent a major burden in Canada, often rooted in unhealthy behaviors established during childhood. Despite recommendations for routine screening, most children are not assessed due to clinical barriers. This paper presents the early development of Project DISCO, a self-administered, digital preappointment tool to screen for and support healthy lifestyle behaviors, including physical activity, sleep, nutrition, and screen time, in children aged 2 to 12 years. Objective: This study aimed to explore clinicians’ and parents’ needs and past experiences with health technology; integrate their insights into the development of a digital tool for promoting health behaviors; and evaluate the usability, relevance, and acceptability of this tool. Methods: Three semistructured focus group and interview sessions were conducted with primary care clinicians and parents. Participants were recruited at the Groupe de Médecine de Famille Universitaire Saint-Hubert using purposive and convenience sampling: clinicians were recruited internally, whereas parents of children aged 2 to 12 years were invited via emails sent by clinic staff. Data were analyzed using a combination of inductive and deductive approaches. Findings informed iterative refinements throughout the codevelopment of the digital tool for promoting healthy lifestyle behaviors in children. Results: A total of 8 participants took part in 6 discussions, including 5 parents of children aged 3 to 12 years and 3 primary care clinicians. Hybrid thematic analysis identified six themes: (1) the potential of a digital tool to promote healthy habits in pediatrics; (2) implementation challenges and opportunities, including integration of the tool into clinical workflow; (3) adherence to and engagement with the tool, with suggestions for reminders and involvement of nurses; (4) perceived limitations and improvement of the screening tool, particularly the nutrition and sleep questionnaires; (5) feedback on the screening report and intervention emphasizing clarity and actionable guidance; and (6) perceived clinical value and opportunity costs. Insights from these discussions guided refinements of the digital tool. Conclusions: The findings support the tool’s relevance and inform its ongoing development. A feasibility study is planned prior to a randomized controlled trial.
- 26 June 2026
- Published by JMIR Publications Inc. in JMIR Pediatrics and Parenting
- Vol. 9, e84304
Open AccessCodevelopment of a Digital Screening and Intervention Tool to Improve Lifestyle Habits in Children: Focus Group Study With Parents and Clinicians
Background: Chronic preventable diseases represent a major burden in Canada, often rooted in unhealthy behaviors established during childhood. Despite recommendations for routine screening, most children are not assessed due to clinical barriers. This paper presents the early development of Project DISCO, a self-administered, digital preappointment tool to screen for and support healthy lifestyle behaviors, including physical activity, sleep, nutrition, and screen time, in children aged 2 to 12 years. Objective: This study aimed to explore clinicians’ and parents’ needs and past experiences with health technology; integrate their insights into the development of a digital tool for promoting health behaviors; and evaluate the usability, relevance, and acceptability of this tool. Methods: Three semistructured focus group and interview sessions were conducted with primary care clinicians and parents. Participants were recruited at the Groupe de Médecine de Famille Universitaire Saint-Hubert using purposive and convenience sampling: clinicians were recruited internally, whereas parents of children aged 2 to 12 years were invited via emails sent by clinic staff. Data were analyzed using a combination of inductive and deductive approaches. Findings informed iterative refinements throughout the codevelopment of the digital tool for promoting healthy lifestyle behaviors in children. Results: A total of 8 participants took part in 6 discussions, including 5 parents of children aged 3 to 12 years and 3 primary care clinicians. Hybrid thematic analysis identified six themes: (1) the potential of a digital tool to promote healthy habits in pediatrics; (2) implementation challenges and opportunities, including integration of the tool into clinical workflow; (3) adherence to and engagement with the tool, with suggestions for reminders and involvement of nurses; (4) perceived limitations and improvement of the screening tool, particularly the nutrition and sleep questionnaires; (5) feedback on the screening report and intervention emphasizing clarity and actionable guidance; and (6) perceived clinical value and opportunity costs. Insights from these discussions guided refinements of the digital tool. Conclusions: The findings support the tool’s relevance and inform its ongoing development. A feasibility study is planned prior to a randomized controlled trial.
- Open Access
- 17 April 2026
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (5) , 103328
Digital Screening Tool to Help Parents and Adolescents Quit Smoking and Vaping: Effectiveness of the CanCEASE Pilot Trial
- 17 April 2026
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (5) , 103328
Open AccessDigital Screening Tool to Help Parents and Adolescents Quit Smoking and Vaping: Effectiveness of the CanCEASE Pilot Trial
- Open Access
- 13 February 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1)
A brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in paediatric medical care in Canada: a pilot randomized controlled trial
Tobacco use is a strong risk factor for premature mortality and morbidity. We assessed the feasibility of screening and recruiting participants for a rando
- 13 February 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1)
Open AccessA brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in paediatric medical care in Canada: a pilot randomized controlled trial
Tobacco use is a strong risk factor for premature mortality and morbidity. We assessed the feasibility of screening and recruiting participants for a rando
- Open Access
- 10 November 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 458-468
Low‐value care and variation in practice in the care of children hospitalized with bronchiolitis in Canada (CareBEST): Protocol for a multi‐center prospective cohort study
Introduction: Low‐value care refers to health services for which the potential harms or costs outweigh the benefits of use. Bronchiolitis is the most common and among the most costly causes of pediatric hospitalizations. Evidence consistently shows that many common tests and treatments used to manage bronchiolitis do not improve outcomes. Further, differential use of low‐value care between patients may perpetuate care inequities. In Canada, rates of low‐value care use in children hospitalized with bronchiolitis, and differences in care across hospitals, clinicians, and patient subgroups, remain poorly characterized. Objective: To understand practice patterns for six low‐value health services in the care of children aged 1–12 months hospitalized for bronchiolitis: respiratory virus testing; chest X‐rays; continuous pulse oximetry; short‐acting beta‐agonists; systemic corticosteroids; and antibiotics. Methods: We are conducting a multi‐center prospective cohort study of children admitted with bronchiolitis in 15 Canadian hospitals. We will use chart reviews to compare low‐value care use between hospitals and clinicians, and caregiver surveys to compare between sociodemographic groups. Questionnaires will also collect caregiver perspectives on their child′s bronchiolitis care, including role in medical decision‐making and understanding of treatment decisions. Discussion: Our study will provide critical information on the usage and variation in delivery of low‐value care for bronchiolitis in Canada, elucidating potential care inequities. Findings will inform the development of interventions to address such inequities, and improve opportunity costs for health systems. Enrollment began in October 2024 and is projected to be completed in May 2026, with analyses and reporting shortly following.
- 10 November 2025
- Published by Wiley in Journal of Hospital Medicine
- Vol. 21 (4) , 458-468
Open AccessLow‐value care and variation in practice in the care of children hospitalized with bronchiolitis in Canada (CareBEST): Protocol for a multi‐center prospective cohort study
Introduction: Low‐value care refers to health services for which the potential harms or costs outweigh the benefits of use. Bronchiolitis is the most common and among the most costly causes of pediatric hospitalizations. Evidence consistently shows that many common tests and treatments used to manage bronchiolitis do not improve outcomes. Further, differential use of low‐value care between patients may perpetuate care inequities. In Canada, rates of low‐value care use in children hospitalized with bronchiolitis, and differences in care across hospitals, clinicians, and patient subgroups, remain poorly characterized. Objective: To understand practice patterns for six low‐value health services in the care of children aged 1–12 months hospitalized for bronchiolitis: respiratory virus testing; chest X‐rays; continuous pulse oximetry; short‐acting beta‐agonists; systemic corticosteroids; and antibiotics. Methods: We are conducting a multi‐center prospective cohort study of children admitted with bronchiolitis in 15 Canadian hospitals. We will use chart reviews to compare low‐value care use between hospitals and clinicians, and caregiver surveys to compare between sociodemographic groups. Questionnaires will also collect caregiver perspectives on their child′s bronchiolitis care, including role in medical decision‐making and understanding of treatment decisions. Discussion: Our study will provide critical information on the usage and variation in delivery of low‐value care for bronchiolitis in Canada, elucidating potential care inequities. Findings will inform the development of interventions to address such inequities, and improve opportunity costs for health systems. Enrollment began in October 2024 and is projected to be completed in May 2026, with analyses and reporting shortly following.
- Open Access
- 28 October 2025
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (1) , 103162
Promoting Scholarly Activity in Pediatric Postgraduate Training: A Scoping Review
- 28 October 2025
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (1) , 103162
Open AccessPromoting Scholarly Activity in Pediatric Postgraduate Training: A Scoping Review
- Open Access
- 17 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Codevelopment of a Digital Screening and Intervention Tool to Improve Lifestyle Habits in Children: Focus Group Study With Parents and Clinicians (Preprint)
BACKGROUND Chronic preventable diseases represent a major burden in Canada, often rooted in unhealthy behaviors established during childhood. Despite recommendations for routine screening, most children are not assessed due to clinical barriers. This paper presents the early development of Project DISCO, a self-administered, digital preappointment tool to screen for and support healthy lifestyle behaviors, including physical activity, sleep, nutrition, and screen time, in children aged 2 to 12 years. OBJECTIVE This study aimed to explore clinicians’ and parents’ needs and past experiences with health technology; integrate their insights into the development of a digital tool for promoting health behaviors; and evaluate the usability, relevance, and acceptability of this tool. METHODS Three semistructured focus group and interview sessions were conducted with primary care clinicians and parents. Participants were recruited at the Groupe de Médecine de Famille Universitaire Saint-Hubert using purposive and convenience sampling: clinicians were recruited internally, whereas parents of children aged 2 to 12 years were invited via emails sent by clinic staff. Data were analyzed using a combination of inductive and deductive approaches. Findings informed iterative refinements throughout the codevelopment of the digital tool for promoting healthy lifestyle behaviors in children. RESULTS A total of 8 participants took part in 6 discussions, including 5 parents of children aged 3 to 12 years and 3 primary care clinicians. Hybrid thematic analysis identified six themes: (1) the potential of a digital tool to promote healthy habits in pediatrics; (2) implementation challenges and opportunities, including integration of the tool into clinical workflow; (3) adherence to and engagement with the tool, with suggestions for reminders and involvement of nurses; (4) perceived limitations and improvement of the screening tool, particularly the nutrition and sleep questionnaires; (5) feedback on the screening report and intervention emphasizing clarity and actionable guidance; and (6) perceived clinical value and opportunity costs. Insights from these discussions guided refinements of the digital tool. CONCLUSIONS The findings support the tool’s relevance and inform its ongoing development. A feasibility study is planned prior to a randomized controlled trial.
- 17 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCodevelopment of a Digital Screening and Intervention Tool to Improve Lifestyle Habits in Children: Focus Group Study With Parents and Clinicians (Preprint)
BACKGROUND Chronic preventable diseases represent a major burden in Canada, often rooted in unhealthy behaviors established during childhood. Despite recommendations for routine screening, most children are not assessed due to clinical barriers. This paper presents the early development of Project DISCO, a self-administered, digital preappointment tool to screen for and support healthy lifestyle behaviors, including physical activity, sleep, nutrition, and screen time, in children aged 2 to 12 years. OBJECTIVE This study aimed to explore clinicians’ and parents’ needs and past experiences with health technology; integrate their insights into the development of a digital tool for promoting health behaviors; and evaluate the usability, relevance, and acceptability of this tool. METHODS Three semistructured focus group and interview sessions were conducted with primary care clinicians and parents. Participants were recruited at the Groupe de Médecine de Famille Universitaire Saint-Hubert using purposive and convenience sampling: clinicians were recruited internally, whereas parents of children aged 2 to 12 years were invited via emails sent by clinic staff. Data were analyzed using a combination of inductive and deductive approaches. Findings informed iterative refinements throughout the codevelopment of the digital tool for promoting healthy lifestyle behaviors in children. RESULTS A total of 8 participants took part in 6 discussions, including 5 parents of children aged 3 to 12 years and 3 primary care clinicians. Hybrid thematic analysis identified six themes: (1) the potential of a digital tool to promote healthy habits in pediatrics; (2) implementation challenges and opportunities, including integration of the tool into clinical workflow; (3) adherence to and engagement with the tool, with suggestions for reminders and involvement of nurses; (4) perceived limitations and improvement of the screening tool, particularly the nutrition and sleep questionnaires; (5) feedback on the screening report and intervention emphasizing clarity and actionable guidance; and (6) perceived clinical value and opportunity costs. Insights from these discussions guided refinements of the digital tool. CONCLUSIONS The findings support the tool’s relevance and inform its ongoing development. A feasibility study is planned prior to a randomized controlled trial.
- Open Access
- 11 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e70517
Using mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study
Background: Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. Objective: The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. Methods: This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. Results: We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. Conclusions: The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.
- 11 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e70517
Open AccessUsing mHealth to Predict Asthma Exacerbations in Children and Adolescents (Mobile Health for Kids With Asthma): Protocol for an Observational Study
Background: Asthma exacerbation is a major cause of emergency department visits in children and adolescents. Most of the existing asthma prediction scores and biomarkers are designed to predict severe exacerbations in the medium to long term. Mobile health (mHealth) is a promising approach for integrating real-time, multimodal data to improve the prediction of asthma exacerbation. Using mHealth can enable the identification of at-risk children and the implementation of timely interventions. Objective: The primary objective of the Mobile Health for Kids With Asthma (MoKA) study is to develop a validated predictive model for imminent asthma exacerbation in children using multimodal data, including participant-reported questionnaires through the RespiSentinel mobile app, augmented with publicly sourced environmental and epidemiological data. Furthermore, we will evaluate the association between the frequency of nocturnal cough measured in real time and asthma control and severe asthma exacerbation, and the acceptability of the RespiSentinel app in asthma self-management. Methods: This is a prospective cohort study with in-person and remote recruitment at 7 tertiary pediatric centers in Canada. Parents of children aged between 1 and 17 years, as well as children who have experienced at least one wheezing episode or asthma exacerbation during the 12 months before recruitment, will be eligible to participate (estimated number of children: n=2000). The planned duration of study participation is 6 months following the date of enrollment (cohort entry), regardless of the number of asthma exacerbations during the follow-up period. The primary outcome will be asthma exacerbation defined by asthma symptoms requiring systemic corticosteroid use and an urgent care or emergency department visit or hospitalization. The predictive model will be created using questionnaire data on asthma control via the RespiSentinel app as well as by integrating publicly available local daily data on air pollutant levels (National Air Pollution Surveillance Program) and weekly prevalence of respiratory viruses (National Canadian Respiratory Virus Detection Surveillance Program). Nocturnal cough frequency will be determined by using nighttime audio recordings, and their contribution to predict imminent asthma exacerbation will be evaluated. Acceptability of the RespiSentinel app will be assessed through an app-based questionnaire. Results: We will train and validate an asthma exacerbation prediction model using multimodal data sources. This approach may help patients, their families, and health professionals anticipate upcoming loss of asthma control and take the necessary steps to prevent a severe asthma exacerbation. Conclusions: The MoKA study will harness real-time mHealth data to identify children at imminent risk of asthma exacerbation with the ultimate goal of designing timely interventions to prevent morbidity in this group of patients.